期刊文献+

miRNA在心脏发育和心血管疾病中的研究进展

The role of miRNA in the development of heart and cardiovascular diseases
原文传递
导出
摘要 miRNA是内源性非编码微小RNA,长度约22个核苷酸。愈是高等生物,miRNA数量愈多,这可能是高等生物生命多样化的原因之一。而且,在不同物种之间,其序列高度保守。miRNA通过调控靶基因表达参与调控多种生物学过程,并且与疾病发生发展密切相关。近来的研究证实,miRNA广泛参与心脏发育和心血管疾病发生发展。本综述将总结miRNA在心血管发育中的作用以及在心脏疾病中的作用机制,探讨目前的miRNA的研究策略,以及miRNA作为诊断标记物和药物治疗靶点的可能性。 miRNA is a type of endogenous, non-coding small RNA, and about 22nt long. The more evolved the creature is, the larger the number of miRNA, which might be the reason of the complexity of lives. As the same time, the sequence of miRNA is highly conserved among different species. It has been found that miRNA plays important roles in many biological processes and closely related to diseases by regulating target genes. Studies of miRNA indicate that miRNA also function in the process of cardiac development and diseases. This review is to conclude the latest advances in the studies of miRNA associated with development of heart and cardiovascular diseases, to discuss the strategy of syudying miRNA, and to explore their possibility as markers for injury and for potential treatment of deseases.
出处 《国际遗传学杂志》 CAS 2011年第6期311-318,332,共9页 International Journal of Genetics
基金 国家自然科学基金(81070131 30400485)
关键词 心脏发育 心血管疾病 微小RNA Development of heart Cardiovascular disease miRNA
作者简介 通信作者:孙开来(E-mail:klsun@mail.cmu.edu.cn)
  • 相关文献

参考文献2

二级参考文献23

  • 1Galie N,Olschewski H,Oudiz R J,et al.Ambrisentan for the treatment of pulmonary arterial hypertension:results of the ambrisentan in pulmonary arterial hypertension,randomized,double-blind,placebo-controlled,multicenter,efficacy(ARIES)study 1 and 2.Circulation,2008,117(23):3010-3019.
  • 2Olschewski H.[Dana Point:what is new in the diagnosis of pulmonary hypertension?.Dtsch Med Wochenschr,2008,133 Suppl 6:S180-S182.
  • 3Du T,Zamore P D.microPrimer:the biogenesis and function of microRNA.Development,2005,132(21):4645-4652.
  • 4Zhu W,Qin W,Atasoy U,et al.Circulating microRNAs in breast cancer and healthy subjects.BMC Res Notes,2009,2:89.
  • 5Cheng Y,Tan N,Yang J,et al.A translational study of circulating cell-free microRNA-I in acute myocardial infarction.Clin Sci(Lond),2010,119(2):87-95.
  • 6Rabinovitch M.Molecular pathogenesis of pulmonary arterial hypertension.J Clin Invest,2008,118(7):2372-2379.
  • 7Archer S L,Gomberg-Maitland M,Maitland M L,et al.Mitochondrial metabolism,redox signaling,and fusion:a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.Am J Physiol Heart Cite Physiol,2008,294(2):H570-H578.
  • 8Archer S L,Marsboom G,Kim G H,et al.Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension:a basis for excessive cell proliferation and a new therapeutic target.Circulation,2010,121(24):2661-2671.
  • 9Klooeterman W P,Plasterk R H.The diverse functions of microRNAs in animal development and disease.Dev Cell,2006,11(4):441-450.
  • 10Mendell J T.MicroRNAs:critical regulators of development,cellular physiology and malignancy.Cell Cycle,2005,4(9):1179-1184.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部